Bile Duct Cancer Global Market Report 2025

Description

Bile duct cancer is a rare malignancy that develops in the bile ducts, which transport bile from the liver to the gallbladder and small intestine. It is often diagnosed in advanced stages and can cause symptoms such as jaundice, weight loss, and abdominal pain.

The primary types of bile duct cancer include extrahepatic bile duct cancer (ECC) and intrahepatic bile duct cancer (ICC). ECC occurs in the bile ducts outside the liver, typically where they exit the liver and connect to the small intestine. Treatment options for ECC include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. It is categorized by stage into localized, regional, and distant forms, with diagnosis typically involving imaging tests, biopsy, and blood tests. These diagnostic and treatment approaches are utilized by various end users, including hospitals, clinics, ambulatory surgical centers, and cancer research institutes.

The bile duct cancer market research report is one of a series of new reports from The Business Research Company that provides bile duct cancer market statistics, including the bile duct cancer industry global market size, regional shares, competitors with the bile duct cancer market share, detailed bile duct cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the bile duct cancer industry. This bile duct cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bile duct cancer market size has grown strongly in recent years. It will grow from $2.39 billion in 2024 to $2.60 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to greater exposure to toxic chemicals, increased awareness of bile duct cancer, a growing geriatric population, a rising incidence of bile duct and pancreatic cancers, and higher investments in healthcare infrastructure.

The bile duct cancer market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be driven by the increasing incidence of bile duct cancer, a rising number of cases of bile duct and liver cancer, a growing prevalence of biliary tract cancers (BTCs), an uptick in research and development activities, and a higher demand for advanced treatment options. Key trends include advancements in diagnostic techniques, innovations in medical technology, improvements in endoscopic imaging, ongoing technological innovations, and the expansion of personalized medicine approaches.

The increasing prevalence of liver diseases is anticipated to drive the growth of the bile duct cancer market. Liver diseases encompass a broad range of conditions that impair liver function, including hepatitis, cirrhosis, fatty liver disease, and liver cancer. The rising incidence of liver diseases is attributed to factors such as excessive alcohol consumption, unhealthy diets, obesity, viral infections (such as hepatitis B and C), and sedentary lifestyles. Bile duct cancer plays a crucial role in understanding liver diseases, as bile duct obstruction or dysfunction often leads to severe liver-related complications, including jaundice and cholestasis. For instance, in April 2024, according to The House of Commons Library, a UK-based government department, 10,593 individuals under the age of 75 in England died from liver disease in 2022, continuing the upward trend in mortality rates. The rate increased from 21.2 per 100,000 population in 2021 to 21.4 per 100,000 in 2022. Consequently, the growing prevalence of liver diseases is fueling the expansion of the bile duct cancer market.

Leading companies in the bile duct cancer market are investing in innovative targeted therapies to enhance treatment outcomes, minimize side effects, and offer new hope to patients facing this rare and complex cancer. Targeted therapies focus on specific genes, proteins, or molecular mechanisms that drive cancer growth, aiming to inhibit tumor progression while reducing systemic toxicity. For example, in August 2023, Taiho Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, introduced FGFR Inhibitor LYTGOBI Tablets 4mg. This oral formulation provides a convenient treatment option, improving patient compliance and ease of administration. LYTGOBI is designed for patients with advanced or metastatic bile duct cancer harboring FGFR2 fusion or rearrangement mutations, addressing a significant unmet need in cancer care.

In July 2023, Lucence, a US-based precision health company, partnered with Innovent Biologics Inc. to enhance molecular diagnostics for bile duct cancer in Hong Kong. Through this collaboration, Lucence aims to integrate Innovent Biologics' advanced targeted therapies into its diagnostic services, improving early detection and personalized treatment approaches for patients. Innovent Biologics Inc. is a China-based biotechnology company specializing in the development, manufacturing, and commercialization of innovative biopharmaceuticals.

Major players in the bile duct cancer market are AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Genentech Inc., Jazz Pharmaceuticals plc, Incyte Corporation, Exelixis Inc., Hutchison China MediTech Limited, Zymeworks Inc., Mirati Therapeutics Inc., RenovoRx Inc., Spectrum Pharmaceuticals Inc., Specialised Therapeutics Pty Ltd, Taiho Pharmaceutical Co. Ltd.

North America was the largest region in the bile duct cancer market in 2024. The regions covered in bile duct cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bile duct cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bile duct cancer market includes revenues earned by entities by services such as diagnostic services, treatment services, clinical trials, and research services, and related products such as pharmaceutical products, diagnostic products, and supportive care products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bile Duct Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bile duct cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bile duct cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bile duct cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Extrahepatic Bile Duct Cancer (eCCA); Intrahepatic Bile Duct Cancer (iCCA)
2) By Treatment Type: Surgery; Chemotherapy; Radiation Therapy; Targeted Therapy; Immunotherapy
3) By Stage of Disease: Localized; Regional; Distant
4) By Diagnosis Type: Imaging Tests; Biopsy; Blood Tests
5) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
Subsegments:
1) By Extrahepatic Bile Duct Cancer (eCCA): Perihilar Cholangiocarcinoma (Klatskin Tumor); Distal Cholangiocarcinoma
2) By Intrahepatic Bile Duct Cancer (iCCA): Mass-Forming iCCA; Periductal Infiltrating iCCA; Intraductal Growth iCCA
Companies Mentioned: AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca plc; Eli Lilly and Company; Gilead Sciences Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33979

1. Executive Summary

2. Bile Duct Cancer Market Characteristics

3. Bile Duct Cancer Market Trends And Strategies

4. Bile Duct Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bile Duct Cancer Growth Analysis And Strategic Analysis Framework

5.1. Global Bile Duct Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bile Duct Cancer Market Growth Rate Analysis
5.4. Global Bile Duct Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bile Duct Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bile Duct Cancer Total Addressable Market (TAM)

6. Bile Duct Cancer Market Segmentation

6.1. Global Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extrahepatic Bile Duct Cancer (eCCA)
Intrahepatic Bile Duct Cancer (iCCA)
6.2. Global Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy
Immunotherapy
6.3. Global Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Localized
Regional
Distant
6.4. Global Bile Duct Cancer Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Tests
Biopsy
Blood Tests
6.5. Global Bile Duct Cancer Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
6.6. Global Bile Duct Cancer Market, Sub-Segmentation Of Extrahepatic Bile Duct Cancer (eCCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Perihilar Cholangiocarcinoma (Klatskin Tumor)
Distal Cholangiocarcinoma
6.7. Global Bile Duct Cancer Market, Sub-Segmentation Of Intrahepatic Bile Duct Cancer (iCCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass-Forming iCCA
Periductal Infiltrating iCCA
Intraductal Growth iCCA

7. Bile Duct Cancer Market Regional And Country Analysis

7.1. Global Bile Duct Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bile Duct Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bile Duct Cancer Market

8.1. Asia-Pacific Bile Duct Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bile Duct Cancer Market

9.1. China Bile Duct Cancer Market Overview
9.2. China Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bile Duct Cancer Market

10.1. India Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bile Duct Cancer Market

11.1. Japan Bile Duct Cancer Market Overview
11.2. Japan Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bile Duct Cancer Market

12.1. Australia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bile Duct Cancer Market

13.1. Indonesia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bile Duct Cancer Market

14.1. South Korea Bile Duct Cancer Market Overview
14.2. South Korea Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bile Duct Cancer Market

15.1. Western Europe Bile Duct Cancer Market Overview
15.2. Western Europe Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bile Duct Cancer Market

16.1. UK Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bile Duct Cancer Market

17.1. Germany Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bile Duct Cancer Market

18.1. France Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bile Duct Cancer Market

19.1. Italy Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bile Duct Cancer Market

20.1. Spain Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bile Duct Cancer Market

21.1. Eastern Europe Bile Duct Cancer Market Overview
21.2. Eastern Europe Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bile Duct Cancer Market

22.1. Russia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bile Duct Cancer Market

23.1. North America Bile Duct Cancer Market Overview
23.2. North America Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bile Duct Cancer Market

24.1. USA Bile Duct Cancer Market Overview
24.2. USA Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bile Duct Cancer Market

25.1. Canada Bile Duct Cancer Market Overview
25.2. Canada Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bile Duct Cancer Market

26.1. South America Bile Duct Cancer Market Overview
26.2. South America Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bile Duct Cancer Market

27.1. Brazil Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bile Duct Cancer Market

28.1. Middle East Bile Duct Cancer Market Overview
28.2. Middle East Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bile Duct Cancer Market

29.1. Africa Bile Duct Cancer Market Overview
29.2. Africa Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bile Duct Cancer Market Competitive Landscape And Company Profiles

30.1. Bile Duct Cancer Market Competitive Landscape
30.2. Bile Duct Cancer Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bile Duct Cancer Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Merck & Co. Inc.
31.3. Boehringer Ingelheim International GmbH
31.4. Eisai Co. Ltd.
31.5. Genentech Inc.
31.6. Jazz Pharmaceuticals plc
31.7. Incyte Corporation
31.8. Exelixis Inc.
31.9. Hutchison China MediTech Limited
31.10. Zymeworks Inc.
31.11. Mirati Therapeutics Inc.
31.12. RenovoRx Inc.
31.13. Spectrum Pharmaceuticals Inc.
31.14. Specialised Therapeutics Pty Ltd
31.15. Taiho Pharmaceutical Co. Ltd.

32. Global Bile Duct Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bile Duct Cancer Market

34. Recent Developments In The Bile Duct Cancer Market

35. Bile Duct Cancer Market High Potential Countries, Segments and Strategies

35.1 Bile Duct Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Bile Duct Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Bile Duct Cancer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer